Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroendocrine Transformation in RB1 and TP53 Inactivated Non-small Cell Lung Cancer Patients: a Multi-center Prospective Observational Study

NCT06369181 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT06369181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06369181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroendocrine Transformation in RB1 and TP53 Inactivated Non-small Cell Lung Cancer Patients: a Multi-center Prospective Observational Study
Lead sponsor
Fudan University
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2021
Completion date
December 31, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

histology transformation, neuroendocrine carcinoma, non-small cell lung cancer